The School of Medicine is participating in the first clinical trial testing atorvastatin to delay or decrease disease in patients who have experienced a first attack of multiple sclerosis (MS).
Statins, of which atorvastatin is one, are a relatively new group of drugs used to lower cholesterol levels. Researchers believe statins may affect the immune system, reducing brain inflammation associated with MS.
To be eligible to enroll in the trial, which is being conducted at 15 sites nationwide, individuals must have experienced a first attack, or clinically isolated syndrome (CIS), lasting at least 48 hours and involving either the optic nerve, spinal cord, brain stem or cerebellum.
"Because permanent neurologic damage can occur during the CIS stage, researchers are seeking new treatments," says Dr. Jana Preiningerova, assistant professor in the Department of Neurology. "Currently, interferon is the only approved therapy for CIS patients, but it has reported side effects and is administered through weekly intra-muscular injections. Atorvastatin, if proven to be effective, can be taken orally and has an established tolerance profile, making it an attractive candidate for patients who need long-term treatment."
The primary objective of the trial is to evaluate the ability of atorvastatin to decrease or delay clinical and MRI-detected disease activity in patients with CIS and MRI findings suggestive of early MS, compared with placebo.
This trial will also examine whether early intervention in patients with CIS may result in a state of immunological tolerance and whether statins have any residual effect after discontinuation.
The trial is being conducted by the Immune Tolerance Network, which is sponsored by the National Institute for Allergy and Infectious Diseases. Sarah Harma is the study coordinator at the School of Medicine. Those interested in participating in the trial can contact her at (203) 764-8160 or sarah.harma@yale.edu.
T H I SW E E K ' SS T O R I E S
Yale community extends helping hand to the victims of Hurricane Katrina
Yale leaders contribute $70,000 to match employee and student donations
Student donates prize money to aid victims of hurricane
Panel examined why Katrina was 'a perfect storm' of failure
Brenzel named undergraduate admissions dean
Studies explore function and formation of feathers
Chinese president's visit postponed
ENDOWED PROFESSORSHIPS
NBA star to discuss his humanitarian efforts in the Congo
Director Sofia Coppola to give Chubb Lecture
Labor-management training aims to foster cooperation
Project explores how cultural outlook impacts opinions
MEDICAL SCHOOL NEWS
'Days of Caring'
Event celebrates 400-year anniversary of 'Don Quixote'
Symposium to examine history of U.S. reach into the Pacific
Scientist Pan invited to participate in NAE symposium
Electrical engineer T.P. Ma is honored for solid-state research
In weekly series, World Fellows will debate global topics
University will celebrate Constitution Day on Sept. 20
Multimedia artist presents photo exhibit and video installation at ISM
'A Taste of Bulgaria' to aid flood victims in another corner of the world
Urban infra-power and urban charisma to be explored in conference
Search committee named for School of Art dean
Biophysical chemist Julian Sturtevant . . .
Memorial service scheduled for . . . Robert Abelson
Alumni magazine now reaches every Yale graduate in the U.S.
Campus Notes
Bulletin Home|Visiting on Campus|Calendar of Events|In the News
Bulletin Board|Classified Ads|Search Archives|Deadlines
Bulletin Staff|Public Affairs|News Releases|
E-Mail Us|Yale Home